Log in

Start Your Membership Now

The Next Phase of AI in Behavioral Health: Putting Clinical Judgment Back in Charge is starting in
About
Contact
Partnership

Become A Member
Log in

Markets
Services
Customers

Market Intel Homepage

Search Library

Publications
Markets
Topics
Executive Institutes
Professional Development Programs
The OPEN MINDS Leadership & Management Certificate The OPEN MINDS CFO Consortium
Tools
Assessments
View By Topic View By Partner

Health Plan Trends

Population Health

Successfully Managing Through Uncertain Times Series

The OPEN MINDS CFO Consortium

The OPEN MINDS Leadership & Management Certificate

Alera Health

ContinuumCloud

Otsuka

View By Topic View By Partner

Acute Care

AI in Analytics

Automation Of Services/Processes

Crisis Management & Technology

Innovation

Integrated Insurance: Risk & Benefits

Medication-Assisted Treatment

Operational Excellence

Transformational Leadership For Non-Profits

Whole Person Care

Adaptive AI In Practice

AI In Process/Workflow Improvement

CCBHCs

Employee Recruitment & Retention

Innovations In Autism & Behavioral Healthcare

IT Operational Efficiency

Metrics-Based Mgmt//Data-Driven Decision Making

Performance Management

Transforming Data To Action

Workforce Optimization

AI/Advanced Technologies To Improve Outcomes

AI Powered Documentation & Compliance

Clinically Integrated Systems Of Care

Hybrid/Virtual Care

Innovations In Housing

Long-Term Services & Supports

Navigating Medicaid

Technology Strategy

Trauma Informed Approaches

ContinuumCloud

Netsmart

Cantata Health Solutions

Clinically AI

Genoa Healthcare

Hartman Executive Advisors

Johnson, Kendall, & Johnson

Mend

Relias

The BI Collaborative

Core Solutions

5e Analytics

Carelon

Eleos

Goodlife Innovations

iCareManager

Juno Health

NextGen Healthcare

ServiceWorks

Vivant Behavioral Healthcare

Qualifacts

Altruix

CCNY

Five Points Technology Group

Grafton Integrated Health Network

Insperity

Medicus IT

Radicle Health

Streamline Healthcare Solutions

Market Intelligence Resource | July 14, 2017

Missouri v. Purdue Pharma, et al.

On June 21, 2017, the State of Missouri sued Purdue Pharma. The state alleges that Purdue Pharma contributed to and profited from the state's opioid epidemic, and that Purdue Pharma falsely represented the relative risks and rewards associated with opioids and non-opioid pain-treatment strategies for its own financial gain.

. . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: